Phospho-TGFβ RII (S225) Polyclonal Antibody, 100µg, (ATB-P1013)

Description

Background:

This gene encodes a member of the Ser/Thr protein kinase family and the TGFB receptor subfamily. The encoded protein is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with another receptor protein, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of a subset of genes related to cell proliferation. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Jul 2008]

Transmembrane serine/threonine kinase forming with the TGF-beta type I serine/threonine kinase receptor, TGFBR1, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFRB1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways.

Product datasheet:

References:

1. Association study of TGFBR2 and miR-518 gene polymorphisms with age at natural menopause, premature ovarian failure, and early menopause among Chinese Han women. Ma X, et al. Medicine (Baltimore), 2014 Oct. PMID 25365407
2. The early manifestation, tumor-specific occurrence and prognostic significance of TGFBR2 aberrant splicing in oral carcinoma. Sivadas VP, et al. Exp Cell Res, 2014 Sep 10. PMID 24846200
3. A reciprocal role of prostate cancer on stromal DNA damage. Banerjee J, et al. Oncogene, 2014 Oct 9. PMID 24141771
4. [Association of single nucleotide polymorphism in TGFBR2 gene with Kawasaki disease and coronary artery lesions]. Shi CP, et al. Zhongguo Dang Dai Er Ke Za Zhi, 2013 Sep. PMID 24034922
5. Mutation of TGF-β receptor II facilitates human bladder cancer progression through altered TGF-β1 signaling pathway. Bian J, et al. Int J Oncol, 2013 Nov. PMID 23970096
6. Expression cloning of the TGF-beta type II receptor, a functional transmembrane serine/threonine kinase.
   Lin H.Y., Wang X.-F., Ng-Eaton E., Weinberg R.A., Lodish H.F.
   Cell 68:775-785(1992) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ALA-439, SUBCELLULAR LOCATION. Tissue: Liver.
7. Erratum
   Lin H.Y., Wang X.-F., Ng-Eaton E., Weinberg R.A., Lodish H.F.
   Cell 70:1069-1069(1992) [PubMed] [Europe PMC]
8. A cDNA encoding the human transforming growth factor beta receptor suppresses the growth defect of a yeast mutant.
   Nikawa J.
   Gene 149:367-372(1994) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). Tissue: Glial cell.
9. The genomic structure of the gene encoding the human transforming growth factor beta type II receptor (TGF-beta RII).
   Takenoshita S., Hagiwara K., Nagashima M., Gemma A., Bennett W.P., Harris C.C.
   Genomics 36:341-344(1996) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), VARIANT ALA-439.
10. Genomic structure of the transforming growth factor beta type II receptor gene and its mutations in hereditary nonpolyposis colorectal cancers.
    Lu S.-L., Zhang W.C., Akiyama Y., Nomizu T., Yuasa Y.
    Cancer Res. 56:4595-4598(1996) [PubMed] [Europe PMC] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), VARIANT ALA-439.